KMT2A and myeloid sarcoma: He was not diagnosed with MS until the genetic results of KMT2A (MLL) gene rearrangement, a common genetic abnormality of AML, were reported, and an expanded antibody panel retested IHC showed positive for CD33 and CD117 (Figure 3).